Successful trial of new drug brings ALS treatment closer to FDA approval
Amyotrophic lateral sclerosis (ALS) is a degenerative neurological condition, but there may soon be another treatment option for the disease as Amylyx Pharmaceuticals finishes successful phase 2 of human trials and moves into phase 3 of a new experimental drug. The new treatment, called Read More...